Skip to main content

Table 3 The genotype distribution and the frequency of alleles of the PAI-1 4G/5G polymorphism in HCC and control groups

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

 HCC patients (n = 50)Control (n = 47)OR (95% confidence interval)p value
 5G/5G1224.01225.51 (reference)Reference
 4G/4G918.01123.40.82 (0.25–2.69)0.978
 4G/5G2958.02451.11.21 (0.46–3.17)0.890
 4G/4G + 4G/5G3876.03574.51.08 (0.43–2.73)0.952
 5G47474851.11 (reference) 
 4G5353.04648.91.17 (0.67–2.07)0.673
  1. Chi-square test, OR odds ratio
  2. If p < 0.05 = not consistent with HWE